Immunity

Immunity is a monthly peer-reviewed journal published by Cell Press, launched in 1994, covering the most important advances in immunology at the molecular, cellular and whole-organism level, with a 2025 Journal Impact Factor of 30.6《免疫》是由（Cell Press）出版、1994 年创办的月度同行评审期刊，刊载分子、细胞与整体生物层面最重要的免疫学进展，2025 年影响因子为 30.6。

Scope

• It publishes studies that provide fundamental new immunological insights at the molecular, cellular or whole-organism level该刊发表在分子、细胞或整体生物层面提供全新免疫学洞见的研究。
• Areas of interest include cancer, infectious disease, neuroimmunology, autoimmune disease, allergy and mucosal immunity其关注领域包括肿瘤、传染病、神经免疫学、自身免疫病、过敏与黏膜免疫。^[1]
• It further covers metabolic disease and homeostasis, alongside immune cell development, signal transduction and gene regulation该刊还涵盖代谢性疾病与稳态，以及免疫细胞发育、信号转导与基因调控。
• Coverage extends to innate and adaptive immunity, transplantation and tumor immunology报道范围延伸至固有免疫与适应性免疫、移植与肿瘤免疫学。
• Article types include original research Articles, Reviews and Perspectives that report major advances文章类型包括报告重大进展的原创研究论文、综述与观点文章。
• It is a hybrid publication, so authors may publish under the subscription model or choose immediate open access该刊为混合出版期刊，作者可选择订阅模式发表，或选择即时开放获取。
• Immunity ranks in the first quartile of the immunology category, with a 2025 Journal Impact Factor of 30.6该刊位于免疫学类别第一四分位，2025 年影响因子为 30.6。

History

• Immunity was launched by Cell Press in 1994, with its first issue appearing in April 1994《免疫》由（Cell Press）于 1994 年创办，首期于 1994 年 4 月出版。
• It was founded to report major advances in immunology and has become one of the field's most prestigious journals该刊创刊以报道免疫学重大进展为使命，如今已成为该领域最具声望的期刊之一。
• Cell Press, based in Cambridge, Massachusetts, is a family of biomedical journals that includes Cell, Molecular Cell and Neuron总部位于马萨诸塞州剑桥的（Cell Press）是涵盖（Cell）、（Molecular Cell）与（Neuron）等刊的生物医学期刊集群。
• Immunity is part of the Cell Press portfolio within Elsevier and publishes twelve monthly issues each year该刊属爱思唯尔旗下（Cell Press）阵营，每年出版十二期月刊。
• Its history spans three decades during which immunology grew into a central discipline of biomedical research该刊历史跨越三十年，其间免疫学已成长为生物医学研究的核心学科。
• Its 2025 Journal Impact Factor is 30.6, and it ranks third among 183 immunology journals其 2025 年影响因子为 30.6，在 183 种免疫学期刊中位列第三。

Editors

• The Editor-in-Chief is Fabiola Rivas, PhD, based in the United States现任主编为 Fabiola Rivas（博士），常驻美国。
• Cell Press journals are run by a team of full-time professional scientific editors rather than an external editorial board（Cell Press）期刊由全职专业科学编辑团队运作，而非外部编委会。
• The editorial team handles a rigorous peer-review process before accepting papers for publication编辑团队在接收论文发表前执行严谨的同行评审流程。
• Manuscripts are assessed for fundamental new insights and for their importance to the broad immunology community稿件依据是否提供全新基础洞见及其对广大免疫学社群的重要性接受评估。
• The journal's editors commission Reviews and Perspectives in addition to considering unsolicited research submissions除受理自由投稿的研究论文外，该刊编辑还组织综述与观点文章的约稿。
• Immunity maintains high editorial standards, and its content is indexed in MEDLINE and the Web of Science该刊维持高标准编辑规范，其内容被（MEDLINE）与（Web of Science）收录。